Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,738031,Alc14,Alcohol consumption QTL 14,7.6,0.00003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,738016,Alc16,Alcohol consumption QTL 16,3.6,0.00015,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,70200,Alc18,Alcohol consumption QTL 18,9.2,,drinking behavior trait (VT:0001422),ethanol intake volume to total fluid intake volume ratio (CMO:0001591),4,55324953,148360954,Rat,n/a,region,qtl 1000,634335,Anxrr16,Anxiety related response QTL 16,7.22,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,94893247,168046938,Rat,n/a,region,qtl 1000,2313402,Anxrr24,Anxiety related response QTL 24,,,aggression-related behavior trait (VT:0015014),tameness/aggressiveness composite score (CMO:0002136),1,49147799,156446783,Rat,n/a,region,qtl 1000,6478760,Anxrr45,Anxiety related response QTL 45,,0.06717,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110702761,155702761,Rat,n/a,region,qtl 1000,6478763,Anxrr46,Anxiety related response QTL 46,,0.07428,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110702761,155702761,Rat,n/a,region,qtl 1000,6478778,Anxrr51,Anxiety related response QTL 51,,0.25384,locomotor behavior trait (VT:0001392),"measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)",4,123587009,168587009,Rat,n/a,region,qtl 1000,12798519,Anxrr54,Anxiety related response QTL 54,2.54,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,112807675,157807675,Rat,n/a,region,qtl 1000,12798523,Anxrr56,Anxiety related response QTL 56,2.83,0.05,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,86312589,147702403,Rat,n/a,region,qtl 1000,12798527,Anxrr58,Anxiety related response QTL 58,4.11,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,120318422,146087100,Rat,n/a,region,qtl 1000,1554320,Bmd1,Bone mineral density QTL 1,12.2,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),1,254393,86904217,Rat,n/a,region,qtl 1000,1578674,Bmd12,Bone mineral density QTL 12,3.8,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),4,137171018,182171018,Rat,n/a,region,qtl 1000,2293659,Bmd35,Bone mineral density QTL 35,4.5,0.0001,femur strength trait (VT:0010010),femoral neck ultimate force (CMO:0001703),4,136908430,182878540,Rat,n/a,region,qtl 1000,2300164,Bmd44,Bone mineral density QTL 44,5.4,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),1,58209327,103209327,Rat,n/a,region,qtl 1000,2313098,Bmd70,Bone mineral density QTL 70,3.6,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313092,Bmd72,Bone mineral density QTL 72,2.5,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313062,Bmd73,Bone mineral density QTL 73,3.9,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,11314489,83657083,Rat,n/a,region,qtl 1000,1578649,Bmd8,Bone mineral density QTL 8,4.9,,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),1,49578577,94578577,Rat,n/a,region,qtl 1000,631683,Bp116,Blood pressure QTL 116,,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,123111827,168111827,Rat,n/a,region,qtl 1000,724520,Bp145,Blood pressure QTL 145,2.1,0.0024,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,21079305,66079305,Rat,n/a,region,qtl 1000,1300172,Bp172,Blood pressure QTL 172,3.56,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),1,35377508,94364229,Rat,n/a,region,qtl 1000,1331738,Bp209,Blood pressure QTL 209,2.979,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,136351734,180689124,Rat,n/a,region,qtl 1000,61342,Bp27,Blood pressure QTL 27,3.4,0.0006,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,57761301,104391981,Rat,n/a,region,qtl 1000,2303168,Bp330,Blood pressure QTL 330,4.25,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,3043231,145254791,Rat,n/a,region,qtl 1000,7421628,Bp361,Blood pressure QTL 361,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,64588516,125875986,Rat,n/a,region,qtl 1000,10059597,Bp377,Blood pressure QTL 377,3.42,0.025,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,35377692,217372257,Rat,n/a,region,qtl 1000,10755501,Bp390,Blood pressure QTL 390,2.5,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),4,23850384,169318094,Rat,n/a,region,qtl 1000,70225,Bp58,Blood pressure QTL 58,3.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,34993530,173445086,Rat,n/a,region,qtl 1000,631495,Bp96,Blood pressure QTL 96,4.52,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,23406428,108057505,Rat,n/a,region,qtl 1000,1578654,Bss10,Bone structure and strength QTL 10,4,,femur morphology trait (VT:0000559),femoral neck cortical cross-sectional area (CMO:0001702),1,49578577,169852184,Rat,n/a,region,qtl 1000,7207480,Bss105,Bone structure and strength QTL 105,8.1,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),4,109636356,154636356,Rat,n/a,region,qtl 1000,1549832,Bss3,Bone structure and strength QTL 3,11,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),4,109636356,154636356,Rat,n/a,region,qtl 1000,2313072,Bss53,Bone structure and strength QTL 53,4.3,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313078,Bss54,Bone structure and strength QTL 54,3.5,0.0001,tibia area (VT:1000281),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313059,Bss55,Bone structure and strength QTL 55,3.2,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313099,Bss56,Bone structure and strength QTL 56,2.4,0.0001,tibia size trait (VT:0100001),tibia midshaft endosteal cross-sectional area (CMO:0001716),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313051,Bss57,Bone structure and strength QTL 57,3.7,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313094,Bss58,Bone structure and strength QTL 58,3.7,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313075,Bss66,Bone structure and strength QTL 66,3.4,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313065,Bss67,Bone structure and strength QTL 67,3.1,0.0001,tibia area (VT:1000281),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313069,Bss68,Bone structure and strength QTL 68,2.9,0.0001,tibia size trait (VT:0100001),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313077,Bss69,Bone structure and strength QTL 69,3.5,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313097,Bss70,Bone structure and strength QTL 70,3.5,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,4889919,Bss86,Bone structure and strength QTL 86,4.1,,tibia area (VT:1000281),tibia midshaft total cross-sectional area (CMO:0001715),1,53851348,83657083,Rat,n/a,region,qtl 1000,4889929,Bss87,Bone structure and strength QTL 87,6.7,,tibia area (VT:1000281),tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722),1,53851348,83657083,Rat,n/a,region,qtl 1000,4889962,Bss94,Bone structure and strength QTL 94,3.8,,tibia area (VT:1000281),tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722),1,49547328,83657083,Rat,n/a,region,qtl 1000,7411558,Bw133,Body weight QTL 133,13.84,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),4,124442168,169442168,Rat,n/a,region,qtl 1000,1354599,Bw29,Body weight QTL 29,3.46,0.001,body mass (VT:0001259),body weight (CMO:0000012),1,34449112,79449112,Rat,n/a,region,qtl 1000,1357400,Bw62,Body weight QTL62,4.05,,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),1,23406428,68406428,Rat,n/a,region,qtl 1000,61422,Cia13,Collagen induced arthritis QTL 13,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,132455408,168047091,Rat,n/a,region,qtl 1000,61434,Cia3,Collagen induced arthritis QTL 3,4.8,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,99066823,144066823,Rat,n/a,region,qtl 1000,61451,Ciaa4,CIA Autoantibody QTL 4,3.1,,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),4,125884464,168047091,Rat,n/a,region,qtl 1000,724535,Cm18,Cardiac mass QTL 18,2.6,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),4,117926139,162926139,Rat,n/a,region,qtl 1000,4889451,Eae29,Experimental allergic encephalomyelitis QTL 29,5.51,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),1,5655772,85706974,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,43414605,155469929,Rat,n/a,region,qtl 1000,1358192,Ept13,Estrogen-induced pituitary tumorigenesis QTL 13,3.4,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),1,24297799,78748000,Rat,n/a,region,qtl 1000,1576316,Ept5,Estrogen-induced pituitary tumorigenesis QTL 5,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),4,84475257,178931073,Rat,n/a,region,qtl 1000,1354612,Foco1,Food consumption QTL 1,8.87,,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),4,43414792,146942075,Rat,n/a,region,qtl 1000,1354643,Foco2,Food consumption QTL 2,7.17,0.0001,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),1,34449112,79449112,Rat,n/a,region,qtl 1000,70201,Gcr1,Gastric cancer resistance QTL 1,2.7,,stomach morphology trait (VT:0000470),stomach tumor susceptibility score (CMO:0002043),4,119705414,146087100,Rat,n/a,region,qtl 1000,2312567,Glom19,Glomerulus QTL 19,1.9,0.006,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),4,49906054,145611886,Rat,n/a,region,qtl 1000,1358202,Gluco11,Glucose level QTL 11,2.4,0.02,adipocyte glucose uptake trait (VT:0004185),absolute change in adipocyte glucose uptake (CMO:0000873),4,86438317,168047091,Rat,n/a,region,qtl 1000,1582232,Gluco25,Glucose level QTL 25,3.6,0.0023,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,86312589,146942261,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,7850904,182171018,Rat,n/a,region,qtl 1000,634347,Hcar8,Hepatocarcinoma resistance QTL 8,5.8,,liver integrity trait (VT:0010547),liver tumorous lesion area to total liver area ratio (CMO:0001075),4,123478354,168478354,Rat,n/a,region,qtl 1000,737821,Hcar9,Hepatocarcinoma resistance QTL 9,3.7,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),4,105971071,168047091,Rat,n/a,region,qtl 1000,631688,Hcas2,Hepatocarcinoma susceptibility QTL 2,3,0.0001,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,5655769,122614963,Rat,n/a,region,qtl 1000,1331759,Hrtrt13,Heart rate QTL 13,3.54628,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,108876717,169215811,Rat,n/a,region,qtl 1000,1300167,Hrtrt2,Heart rate QTL 2,4.35,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),1,11314489,75844121,Rat,n/a,region,qtl 1000,1300116,Hrtrt5,Heart rate QTL 5,3.76,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,115372758,150038284,Rat,n/a,region,qtl 1000,631674,Iddm14,Insulin dependent diabetes mellitus QTL 14,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,63537179,157286626,Rat,n/a,region,qtl 1000,9589820,Insglur3,Insulin/glucose ratio QTL 3,10.75,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),1,35854167,80854167,Rat,n/a,region,qtl 1000,2293840,Kiddil9,Kidney dilation QTL 9,2.9,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),4,120400597,146942261,Rat,n/a,region,qtl 1000,2298545,Neuinf8,Neuroinflammation QTL 8,4.6,,nervous system integrity trait (VT:0010566),spinal cord beta-2 microglobulin mRNA level (CMO:0002125),1,58354072,161711996,Rat,n/a,region,qtl 1000,634314,Niddm44,Non-insulin dependent diabetes mellitus QTL 44,,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,49578693,217054291,Rat,n/a,region,qtl 1000,61362,Oia2,Oil induced arthritis QTL 2,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,136351734,174694858,Rat,n/a,region,qtl 1000,1298524,Oia8,Oil induced arthritis QTL 8,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,136351734,174694858,Rat,n/a,region,qtl 1000,737978,Pia23,Pristane induced arthritis QTL 23,5.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131532269,168047091,Rat,n/a,region,qtl 1000,2302049,Pia32,Pristane induced arthritis QTL 32,5.1,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112),4,105277348,150277348,Rat,n/a,region,qtl 1000,2302059,Pia36,Pristane induced arthritis QTL 36,3.8,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),1,41907249,86907249,Rat,n/a,region,qtl 1000,631511,Pia7,Pristane induced arthritis QTL 7,4.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131532269,168047091,Rat,n/a,region,qtl 1000,8552900,Pigfal1,Plasma insulin-like growth factor 1 level QTL 1,7.4,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),1,35854167,80854167,Rat,n/a,region,qtl 1000,8552948,Pigfal11,Plasma insulin-like growth factor 1 level QTL 11,4.7,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),1,35854167,80854167,Rat,n/a,region,qtl 1000,724558,Plsm2,Polydactyly-luxate syndrome (PLS) morphotypes QTL 2,,0.0003,hindlimb integrity trait (VT:0010563),hind foot phalanges count (CMO:0001949),4,131834282,176834282,Rat,n/a,region,qtl 1000,1331785,Rf27,Renal function QTL 27,4.643,,urine sodium amount (VT:0006274),urine sodium level (CMO:0000129),1,31489454,79689689,Rat,n/a,region,qtl 1000,1331778,Rf28,Renal function QTL 28,4.66,,urine potassium amount (VT:0010539),urine potassium excretion rate (CMO:0000761),1,46113461,79689689,Rat,n/a,region,qtl 1000,1331792,Rf29,Renal function QTL 29,4.589,,urine potassium amount (VT:0010539),urine potassium level (CMO:0000128),1,36033165,79689689,Rat,n/a,region,qtl 1000,738009,Sach4,Saccharine consumption QTL 4,4.9,0.000016,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,58640017,154427984,Rat,n/a,region,qtl 1000,1354660,Salc1,Saline consumption QTL 1,11.26,,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),4,43414792,146942075,Rat,n/a,region,qtl 1000,6903308,Scl36,Serum cholesterol QTL 36,2,0.0125,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),1,50522714,94225616,Rat,n/a,region,qtl 1000,1549827,Scl46,Serum cholesterol level QTL 46,3.5,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),4,131864442,176864442,Rat,n/a,region,qtl 1000,61406,Scwia1,Streptococcal cell wall induced arthritis QTL 1,2.3,,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),4,105682594,150682594,Rat,n/a,region,qtl 1000,1358359,Sradr1,Stress Responsive Adrenal Weight QTL 1,4.74,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),1,25951907,130917265,Rat,n/a,region,qtl 1000,1358364,Sradr4,Stress Responsive Adrenal Weight QTL 4,4.92,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),4,128602727,173602727,Rat,n/a,region,qtl 1000,1358352,Srcrt3,Stress Responsive Cort QTL 3,2.29,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,36615599,145611886,Rat,n/a,region,qtl 1000,1331732,Srn4,Serum renin concentration QTL 4,4.467,,renin activity (VT:0005581),plasma renin activity level (CMO:0000116),1,36033165,79689689,Rat,n/a,region,qtl 1000,1331802,Srn5,Serum renin concentration QTL 5,3.045,,renin activity (VT:0005581),plasma renin activity level (CMO:0000116),4,116726724,157291438,Rat,n/a,region,qtl 1000,1298082,Stresp4,Stress response QTL 4,,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,46898276,145611886,Rat,n/a,region,qtl 1000,731165,Uae21,Urinary albumin excretion QTL 21,2.4,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),4,106347236,151347236,Rat,n/a,region,qtl 1000,2303623,Vencon2,Ventilatory control QTL 2,3.8,,respiration trait (VT:0001943),minute ventilation (VE) (CMO:0000132),4,134917642,179917642,Rat,n/a,region,qtl 1000,70177,Xhs1,X-ray hypersensitivity QTL 1,25.1,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,81959983,152055009,Rat,n/a,region,qtl